FFCP PHASE1:Hg19::chr10:26727225..26727239,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p5@APBB1IP |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_5_at_APBB1IP_5end |
| Coexpression cluster: | NA |
| Association with transcript: | -26bp_to_NM_019043, uc001isr.2, uc001iss.2, uc009xks.1_5end |
| EntrezGene: | APBB1IP |
| HGNC: | 17379 |
| UniProt: | Q7Z5R6Q8IYL7Q9NWJ6 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p5@APBB1IP |
|---|
0.0
2.5
5.0
7.5
10.0
12.5
15.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| lymphocyte of B lineage | 1.00e-23 | 24 |
| pro-B cell | 1.00e-23 | 24 |
| mesenchymal cell | 4.43e-23 | 354 |
| connective tissue cell | 5.26e-22 | 361 |
| B cell | 2.84e-18 | 14 |
| motile cell | 2.97e-18 | 386 |
| hematopoietic stem cell | 1.51e-16 | 168 |
| fat cell | 1.98e-16 | 15 |
| stem cell | 1.23e-15 | 441 |
| multi fate stem cell | 1.99e-15 | 427 |
Showing 1 to 10 of 20 entries
| Ontology term | p-value | n |
|---|---|---|
| connective tissue | 2.38e-21 | 371 |
| cavity lining | 7.05e-12 | 12 |
| serous membrane | 7.05e-12 | 12 |
| adipose tissue | 7.95e-10 | 14 |
| omentum | 2.72e-08 | 6 |
| peritoneum | 2.72e-08 | 6 |
| abdominal cavity | 2.72e-08 | 6 |
| visceral peritoneum | 2.72e-08 | 6 |
Showing 1 to 8 of 8 entries
| Ontology term | p-value | n |
|---|---|---|
| hematologic cancer | 9.57e-16 | 51 |
| immune system cancer | 9.57e-16 | 51 |
| leukemia | 1.82e-13 | 39 |
| myeloid leukemia | 5.27e-11 | 31 |
Showing 1 to 4 of 4 entries
